BACKGROUND: A recent case-controlled study reported an increased risk of diabetes
mellitus in patients treated with inhaled corticosteroids for asthma or COPD, versus age …

BACKGROUND:: Systemic corticosteroids are known to increase diabetes risk, but the
effects of high-dose inhaled corticosteroids are unknown. We assessed whether the use and …

Rationale: Inhaled corticosteroids (ICS) are the mainstay of asthma treatment. Studies in
chronic obstructive pulmonary disease reported increased rates of pneumonia with ICS …

Objective: To determine the effect of inhaled corticosteroid (ICS) therapy on glucose control
in adults with type 2 diabetes mellitus and coexisting asthma or chronic obstructive …

Aim To determine the risk of type 2 diabetes onset associated with accumulated inhaled
corticosteroids (ICS) dose during the previous year in patients with chronic obstructive …

Background In clinical trials, the use of inhaled corticosteroids is associated with an
increased risk of pneumonia in people with COPD, but whether the same is true for people …

Inhaled corticosteroids are considered an important therapy for asthma. They have potent
local effects and few adverse systemic effects [1, 2]. Oral corticosteroid administration …

Background Concerns remain about the safety of adding long-acting β2-agonists to inhaled
glucocorticoids for the treatment of asthma. In a postmarketing safety study mandated by the …

Aim Studies have linked the use of inhaled corticosteroids (ICSs) to excess pneumonia risk
in chronic obstructive pulmonary disease patients. The risk in asthma patients remains …

Abstract Background: Oral corticosteroids (OCSs) are often used to achieve asthma control.
OCS-related comorbidities increase the burden of disease for patients and healthcare …